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Summary
Breast malignancies are one of the most prevalent and major causes of morbidity and mor-
tality among women worldwide. According to the available data, neoplastic lesions of the 
breast are one of the main causes leading to heavy costs for both the healthcare system and 
the society. Based on these realities and the fact that different aspects of these malignancies 
remain unknown to date, and are essential to be determined, these issues make a vast area 
of research in medicine. Just like the present time, breast neoplasms were under the focus of 
scientists lived in the past, from all over the world. Accordingly, these malignancies are a 
group of disease with a long-standing historical background. As a result, it can be claimed 
that modern-day knowledge of these matters has burgeoned on the extraordinary discoveries 
and the development of diagnostic and therapeutic methods made through the ages, espe-
cially those of the post-medieval era. Recognizing the previous efforts that have been made in 
this regard will show our future way for us. For this reason, in this paper, we will review the 
key milestones and vital discoveries in the field of breast neoplasms and some other diseases 
involving this body organ.
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Introduction
Because of the consequent morbidity, mortality, medical costs, and need 
for long-term care associated with breast neoplasms, these diseases have 
been and remain a main point of attention in the medical community. As 
old as the art of surgery, breast neoplasms trace their history back to ancient 
times. In spite of the long history of neoplastic lesions of the breast, an im-
portant part of the present knowledge regarding them and their diagnosis 
and management was acquired through many years of effort and experience 
during the post-medieval era [1-4]. This paper summarizes key milestones 
in the development of modern knowledge of breast neoplasms (as the main 
point) and some other conditions affecting this body part.
A synopsis of advancements in the 
diagnosis of breast diseases
Benign Lesions
Fat necrosis: Fat necrosis is a benign and non-suppurative inflammato-
ry process of adipose tissue. It is responsible for 2.75% of all benign breast 
lesions [5]. It was first described by Burton J. Lee and Frank Adair from the 
Memorial Hospital, New York, in 1924 [6].
Granular cell tumor: Granular cell tumors are a rare and usually benign 
neoplasm which may occur in any part of the body. Approximately 5% to 8% 
of granular cell tumors occur within the breast [7]. It was first described by 
A. Abrikossoff, a Russian pathologist, in 1926 [8].
Fibroadenoma: Fibroadenoma is a common and benign breast lesion 
which usually presents as a single breast mass in young women [9]. Eccrine 
syringofibroadenoma is a rare eccrine tumor first described by JM Mascaro in 
1963 [10]. Complex fibroadenomas were first described by William D. Dupont 
and his colleagues from the Vanderbilt University School of Medicine, 
Nashville, USA, in 1994 [11].
Adenoma: Syringomatous adenoma of the nipple was first described 
by Paul Peter Rosen in 1983 [12]. Ductal adenoma was first described by J. G. 
Azzopardi and Richard Salm (from Royal postgraduate Medical School, UK) 
in 1984 [13]. 
Pseudoangiomatous stromal hyperplasia: Pseudoangiomatous stromal hy-
perplasia of the breast is a benign proliferative lesion of the mammary stroma 
which rarely presents as a localized mass [14]. This type of breast neoplasm 
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was first described by Milan F. Vuitch and his colleagues, a group from the 
Memorial Sloan-Kettering Cancer Center, USA, in 1986 [15].
Myofibroblastoma: Breast myofibroblastomas are rare, benign tumors 
which occur predominantly in men in their 6th to 7th decade of life [16]. It was 
first described by Eric S. Wargotz, a pathologist from the George Washington 
University Medical Center, USA, and his colleagues in 1987 [17].
Pre-Malignant Lesions
Mucocele-like tumor: A mucocele-like tumor is a benign lesion of the 
breast which can be associated with ductal atypical hyperplasia, intraductal 
carcinoma, and infiltrating mucinous (colloid) carcinoma [18]. This patho-
logic entity was first described in 1986 by Paul Peter Rosen as a benign lesion 
of the breast consisting of multiple cysts of mucinous material that have rup-
tured and discharged their contents into the surrounding stroma [19].
Ductal carcinoma in situ: Ductal carcinoma in situ, or intraductal car-
cinoma, is a non-invasive form of breast cancer which has a 25% incidence 
rate among American wom-
en with breast malignancies 
[20]. This type of pathology 
was first described by Albert 
Compton Broders (1885-1964) 
(Fig. 1), an American surgical 
pathologist, in 1932 [21]. In ad-
dition, this pathologist creat-
ed a microscopic system for 
grading cancerous lesions in 
1920 [22, 23].
Lobular carcinoma in situ: 
Presently, lobular carcino-
ma in situ can be an indolent 
precursor of invasive lobular 
cancer of the breast [24]. This 
diagnosis was first described 
in 1941 by Frank W. Foote (1911-
1989) and Fred W. Stewart 
(1894-1991), two American 
surgical pathologists, as a 
Fig. 1. Albert C. Broders (1885-1964). 
(Reproduced with permission from the Wright 
JR Jr (2012) Albert C. Broders’ paradigm shifts 
involving the prognostication and definition of 
cancer. Arch Pathol Lab Med 136:1437-1446.)
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noninvasive lesion arising from the terminal ducts and lobules of the breast 
[25].
Hypersecretory ductal carcinoma in situ: Hypersecretory cellular changes 
in lesions of the breast may represent the evolution of in situ forms of the 
disease toward cancer [26]. This pathologic diagnosis was first introduced by 
Paul Peter Rosen and Marian Scott (Memorial Sloan-Kettering Cancer Center, 
USA) in 1984 [27].
Malignant Lesions
Liposarcoma: Liposarcoma of the mammary glands is a rare malignant 
tumor that has an incidence of 0.3% of all sarcomas of the breast [28]. This 
type of breast pathology was first reported by Ernst Neumann (1834-1918), a 
German pathologist, in 1862 [29].
Myeloid sarcoma: The presentation of myeloid sarcoma as a breast mass 
is very rare and usually occurs in cases with a prior history of acute myeloid 
leukemia or other myeloid disorders [30]. This condition was first described 
by Allan Burns (1781-1813), a Scottish surgeon and physician, in 1811 [31].
Tubular carcinoma: Tubular carcinoma of the breast is an uncommon his-
tological subtype of invasive breast cancer that accounts for approximate-
ly 1% to 5% of invasive breast carcinomas. It has an excellent prognosis [32]. 
This pathologic entity was 
first described by Victor Cornil 
(1837-1908) and Louis-Antoine 
Ranvier (1835-1922), two French 
pathologists, in 1869 [33].
Paget’s disease: Paget’s 
disease of the nipple is an 
uncommon type of breast 
neoplasm which usually pres-
ents itself as a pruritic and ec-
zema-like rash involving the 
nipple-areolar complex [34]. 
Mammary Paget’s disease was 
first described in 1874 by the 
English surgeon and patholo-
gist Sir James Paget (1814-1899) 
(Fig. 2) [35].
Fig. 2. Sir James Paget (1814 - 1899)
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Angiosarcoma: Angiosarcoma of the breast is an infrequent and highly 
malignant form of breast sarcoma that has a poor prognosis because of the 
frequency of metastasis and recurrence [36]. It was first described by Georg 
Benno Schmidt in 1887 [37].
Invasive apocrine carcinoma: Invasive apocrine carcinoma of the breast is 
a rare, unique, and morphologically distinctive type of invasive ductal carci-
noma [38]. This type of breast pathology was first described by E. Krompecher, 
a German pathologist, in 1916 [39].
Carcinoma erysipeloides: Carcinoma erysipeloides is an uncommon but 
distinctive form of cutaneous metastasis. It is most frequently associated 
with carcinoma of the breast, but may occur with other primary tumors 
[40]. In 1924, for the first time, Burton J. Lee and N. Tannenbaum from the 
Memorial Hospital of New York reported the association of breast cancer 
with inflammatory changes in the overlying skin [41]. This pathology was 
given its current name by Carl Emanuel Flemming Rasch (1861-1938), a Danish 
physician, in 1931 [42].
Adenoid cystic carcinoma: Adenoid cystic carcinoma (ACC) of the 
breast, previously called “cylindroma”, is a rare form of primary breast can-
cer which is responsible for less than 0.1% of all primary breast malignan-
cies [43]. Although Theodor 
Billroth (1829-1894) (Fig. 3), 
an Austrian surgeon and the 
founding father of modern 
abdominal surgery, intro-
duced the clinical and patho-
logic features of ACC of the 
trachea in 1859 and coined the 
term “cylindroma” for this 
diagnosis, Charles Freeman 
Geschickter (1901-1987), an 
American pathologist, and 
Murray Marcus Copeland 
(1902-1982), an American can-
cer specialist, were the first to 
report ACC of the breast in 
1945 [44, 45].
Fig. 3. Theodor Billroth (1829 - 1894)
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Invasive lobular carcinoma: Invasive lobular carcinoma of the breast is re-
sponsible for 10% to 15% of all newly diagnosed breast cancers [46]. It was first 
described by Frank W. Foote and Fred W. Stewart in 1946 [47].
Medullary carcinoma: Medullary carcinoma of the breast is an invasive 
and uncommon form of breast cancer and has a prevalence of less than 5% of 
breast malignancies [48]. This class of breast pathology was first described by 
Oliver S. Moore and Frank W. Foote from the Memorial Hospital, New York, 
in 1949 [49].
Lipid-rich carcinoma: Lipid-rich carcinoma of the breast is a very rare vari-
ant of breast malignancies which is responsible for less than 1% of all breast 
cancers. The morphology of this carcinoma was first described by Michel H. 
Aboumrad and his colleagues at the Henry Ford Hospital, USA in 1963. The 
relation of lipid-rich carcinoma and neuroleptics (prolactin releasing drugs) 
was first described by Tsubura and his colleagues in 1992 [50-52].
Secretory carcinoma: Secretory carcinoma of the breast, previously called 
“juvenile breast cancer”, is a rare and low-grade type of breast cancer which 
can occur in the adult age group and can affect both male and female [53]. It 
was first described by Robert W. McDivitt and Fred W. Stewart in 1966 [54].
Adenomyoepithelioma: Adenomyoepithelioma of the breast is an uncom-
mon and low-grade malignant neoplasm which has the potential of distance 
metastases [55]. This pathologic class was first described by H. Hamperl, a 
German pathologist, in 1970 [56].
Tubulolobular carcinoma: Tubulolobular carcinoma is a rare subtype 
of breast cancer which presents characteristics of both lobular and ductal 
differentiation [57]. This pathologic diagnosis was first reported by Edwin 
R. Fisher and his colleagues, a group of physicians from the University of 
Pittsburgh School of Medicine, in 1977 [58].
Breast carcinoma with choriocarcinomatous features: Mammary carcinoma 
with choriocarcinomatous features is a rare and distinct variant of metaplas-
tic carcinoma in which focal choriocarcinomatous differentiation occurs [59]. 
It was first described by Patricia E. Saigo and Paul Peter Rosen, two American 
physicians, in 1981 [60].
Glycogen-rich clear cell carcinoma: Glycogen-rich clear cell carcino-
ma of the breast is an uncommon form of breast cancer which accounts 
for 0.9% to 2.8% of all breast cancer cases [61]. This pathologic finding was 
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first explained in 1981 by Meredith T. Hull and his co-workers, a group from 
Indiana University School of Medicine, USA [62].
Low-grade adenosquamous carcinoma: Low-grade adenosquamous car-
cinoma of the breast is a rare form of invasive mammary carcinoma [63]. 
It was first reported by Paul Peter Rosen and his colleague Debra Ernsberger 
(Memorial Sloan-Kettering Cancer Center, USA) in 1987 [64].
Invasive micropapillary carcinoma: Invasive micropapillary carcinoma of 
the breast is an uncommon and highly aggressive type of breast cancer [65]. 
This type of breast malignancy was first described by Sumalee Siriaunkgul 
and Fattaneh Abbas-Zadeh Tavassoli, two pathologists from USA, in 1993 [66].
Acinic cell carcinoma: Primary acinic cell carcinoma of the breast is a very 
rare condition that has pathology similar to that of acinic cell carcinoma of 
the salivary glands [67]. Acinic cell carcinoma was first identified by Federico 
Roncaroliand his colleagues, a group of scientists from two institutes in Italy 
and Slovenia, in 1996 [68].
Other Breast Pathologies
Breast tuberculosis: Mammary tuberculosis is a rare form of tuberculo-
sis which involves the breast [69]. It was first recorded in 1829 by Sir Astley 
Cooper (1768-1841) (Fig. 4), an English surgeon and anatomist, as what he 
called “scrofulous swelling of the 
bosom” [70]. Cooper’s one oth-
er great contribution to mod-
ern knowledge of the breast 
was his description of the sus-
pensory support system of the 
breast (presently known as 
Cooper’s ligament). In addi-
tion, he authored two books 
about the breast, including 
Illustrations of the Diseases of 
the Breast (published in 1829) 
and On the Anatomy of the 
Breast (published in 1832) [71].
Phyllodes tumor: Phyllodes 
tumors are uncommon tu-
mors of the breast that occur 
Fig. 4. Sir Astley Paston Cooper (1768 - 1841)
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in middle-aged women and can be classified into the categories of benign, 
borderline, and malignant based on histological features [72]. Phyllodes 
tumors were first described by the German scientist Johannes Peter Müller 
(1801-1858) in 1838 when he used the term “sarcoma” for this type of breast 
neoplasm because of its gross fleshy appearance [73].
Ectopic breast tissue: Ectopic breast tissue can present anywhere along the 
primitive embryonic milk lines (from the axilla to the groin) [74]. Hartung first 
introduced this diagnosis in 1872 when he reported a thirty-year-old woman 
with a fully formed mammary gland in the left labium majus [75, 76]. Later, 
in 1936, Harry J. Greene, an American physician, described the first known 
diagnosed case of adenocarcinoma arising in ectopic mammary tissue [77].
Occult breast cancer: Occult pri-
mary breast carcinoma is an uncom-
mon type of breast cancer which 
presents itself with axillary metasta-
sis [78]. It was first described by the 
American surgeon William Stewart 
Halsted (1852-1922) (Fig. 5) in 1907 [79]. 
This physician made another major 
contribution to the field of breast 
cancer management, i.e., the devel-
opment of the radical mastectomy as 
a treatment for breast malignancies 
[80].
Breast sarcoidosis: J. Strandberg 
was probably the first to present a 
case of breast sarcoidosis in 1921. His 
reported patient had suffered from 
systemic sarcoidosis with bilater-
al breast nodules. Although Strandberg believed that the presence of such 
nodules was representative of sarcoidosis, he was unable to confirm sarcoid 
involvement of the breast [81]. After him, in 1938, R. Bodley Scott described the 
first case of breast sarcoidosis with adequate clinical and histological find-
ings [82].
Hamartoma: Hamartoma of the breast is a rare, benign, and tumor-like 
malformation of glandular, adipose, and fibrous tissue [83]. Mammary ham-
artomas were first described in 1971 by Marco G. Arrigoni and his co-workers 
Fig. 5. William Stewart Halsted 
(1852 - 1922)
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in a study of 10 patients whose breast tumors clinically and grossly resembled 
fibroadenomas [84].
Granulomatous mastitis: Granulomatous mastitis is a rare, chronic, and 
inflammatory condition of the breast with an unknown etiology that affects 
women of child-bearing age [85]. This diagnosis was first described by the 
two physicians Edward Kessler and Yaakov Wolloch in 1972 [86].
Diabetic mastopathy: Diabetic mastopathy is an uncommon kind of lym-
phocytic mastitis and stromal fibrosis which typically occurs in patients 
with longstanding type one diabetes [87]. It was first described by the two 
physicians Norman G. Soler and Romesh Khardori from the Southern Illinois 
University School of Medicine in 1984 [88].
Conclusion
Present-day knowledge of breast neoplasms, their screening, diagnosis, 
and their management is highly indebted to the previous and continuous 
efforts made in this field. Yet there are still many unknown aspects of neo-
plastic lesions of the breast. This means that there is still a strong need for 
further efforts to improve the current status of diagnosis and therapy for dis-
eases of the breast, a task which could affect the lives of a large number of the 
population.
References
1. Retief FP, Cilliers L. Breast cancer in antiquity. S Afr Med J. 2011;101:513-5.
2. Sakorafas GH, Safioleas M. Breast cancer surgery: an historical narrative. Part I. 
From prehistoric times to Renaissance. Eur J Cancer Care (Engl). 2009;18:530-44.
3. Sakorafas GH, Safioleas M. Breast cancer surgery: an historical narrative. Part 
II. 18th and 19th centuries. Eur J Cancer Care (Engl). 2010;19:6-29.
4. Sakorafas GH, Safioleas M. Breast cancer surgery: an historical narrative. Part 
III. From the sunset of the 19th to the dawn of the 21st century. Eur J Cancer 
Care (Engl). 2010;19:145-66.
5. Upadhyaya VS, Uppoor R, Shetty L. Mammographic and sonographic features 
of fat necrosis of the breast. Indian J Radiol Imaging. 2013;23:366-72.
6. Lee BJ, Adair FE. Traumatic fat necrosis of the female breast and its differentia-
tion from carcinoma. Ann Surg. 1924;80:670-91.
7. Mátrai Z, Langmár Z, Szabó E, Rényi-Vámos F, Bartal A, Orosz Z, et al. Granular 
cell tumour of the breast: case series and review of the literature. Eur J Gynaecol 
Oncol. 2010;31:636-40.
435
8. Abrikossoff A. Über myome, ausgehend von der quergestreiften willkürlichen 
muskulatur. Virchows Arch Pathol Anat. 1926;260:215-33.
9. Sklair-Levy M, Sella T, Alweiss T, Craciun I, Libson E, Mally B. Incidence and 
management of complex fibroadenomas. AJR Am J Roentgenol. 2008;190:214-8.
10. Mascaró JM. Considérationssur les tumeursfibroépithéliales: le syringofibroad-
enomeeccrine. Ann Dermatol Syphilol. 1963;90:146-53.
11. Dupont WD, Page DL, Parl FF, Vnencak-Jones CL, Plummer WD Jr, Rados MS, 
et al. Long-term risk of breast cancer in women with fibroadenoma. N Engl J 
Med. 1994;331:10-5.
12. Rosen PP. Syringomatous adenoma of the nipple. Am J Surg Pathol. 1983;7:739-45.
13. Azzopardi JG, Salm R. Ductal adenoma of the breast: a lesion which can mimic 
carcinoma. J Pathol. 1984;144:15-23.
14. AbdullGaffar B. Pseudoangiomatous stromal hyperplasia of the breast. Arch 
Pathol Lab Med. 2009;133:1335-8.
15. Vuitch MF, Rosen PP, Erlandson RA. Pseudoangiomatous hyperplasia of mam-
mary stroma. Hum Pathol. 1986;17:185-91.
16. Rafique A, Arshad A. Myofibroblastoma: an unusual rapidly growing benign 
tumour in a male breast. J Coll Physicians Surg Pak. 2013;23:818-9.
17. Wargotz ES, Weiss SW, Norris HJ. Myofibroblastoma of the breast. Sixteen cases 
of a distinctive benign mesenchymal tumor. Am J Surg Pathol. 1987;11:493-502.
18. Berardi R, Latini L, Santinelli A, Herber N, Baldassarre S, Scartozzi M, et al.Mu-
cocele-like tumour of the breast. J ExpClin Cancer Res. 2003;22:329-32.
19. Rosen PP. Mucocele-like tumors of the breast. Am J Surg Pathol. 1986;10:464-9.
20. Virnig BA, Tuttle TM, Shamliyan T, Kane RL. Ductal carcinoma in situ of the 
breast: a systematic review of incidence, treatment, and outcomes. J Natl Cancer 
Inst. 2010;102:170-8.
21. Broders AC. Carcinoma in situ contrasted with benign penetrating epithelium. 
JAMA. 1932;99:1670-4.
22. Broders AC. The grading of carcinoma. Minn Med. 1925;726-30.
23. Broders AC. The microscopic grading of cancer. Surg Clin North Am. 
1941;21:947-62.
24. Cocquyt V, Van Belle S. Lobular carcinoma in situ and invasive lobular cancer 
of the breast. Curr Opin Obstet Gynecol. 2005;17:55-60.
25. Foote F, Stewart F. Lobular carcinoma in situ: a rare form of mammary cancer. 
Am J Pathol. 1941;17:491-6.
26. Povoski SP, Barsky SH. In situ carcinomas of the breast: Ductal carcinoma in 
situ and lobular carcinoma in situ. In: Bland KI, Copeland CM, editors. The 
breast: comprehensive management of benign and malignant diseases. Vol. 1. 
USA: Elsevier Saunders; 2009.
436
27. Rosen PP, Scott M. Cystic hypersecretory duct carcinoma of the breast. Am J 
Surg Pathol. 1984;8:31-41.
28. Parikh BC, Ohri A, Desai MY, Pandya SJ, Dave RI. Liposarcoma of the breast--a 
case report. Eur J Gynaecol Oncol. 2007;28:425-7.
29. Pant I, Kaur G, Joshi SC, Khalid IA. Myxoidliposarcoma of the breast in a 
25-year-old female as a diagnostic pitfall in fine needle aspiration cytology: re-
port of a rare case. Diagn Cytopathol. 2008;36:674-7.
30. Valbuena JR, Admirand JH, Gualco G, Medeiros LJ. Myeloid sarcoma involving 
the breast. Arch Pathol Lab Med. 2005;129:32-8.
31. Burns A. Observations on the surgical anatomy of the head and neck. Edinburgh: 
Thomas Royce & Co;1811. pp. 364-366.
32. Min Y, Bae SY, Lee HC, Lee JH, Kim M, Kim J, et al. Tubular carcinoma of the 
breast: clinicopathologic features and survival outcome compared with ductal 
carcinoma in situ. J Breast Cancer.2013;16:404-9.
33. Cornil V, Ranvier L. Manuel d’histologiepathologique. Paris: Germer-Baillière; 
1869. 
34. Trebska-McGowan K, Terracina KP, Takabe K. Update on the surgical manage-
ment of Paget’s disease. Gland Surg. 2013;2(3).
35. Paget J. On disease of the mammary areola preceding cancer of the mammary 
gland. St. Bartholomew’s Hospital Reports. 1874;10:87-9.
36. Keshav P, Hegde SS. Bilateral primary angiosarcoma of the breast. Case Rep 
Surg. 2013;2013:139276.
37. Schmidt GB. Ueber das angiosarkom der mamma. Arch Klin Chir. 1887;36:421–7.
38. Tanaka K, Imoto S, Wada N, Sakemura N, Hasebe K. Invasive apocrine carcino-
ma of the breast: clinicopathologic features of 57 patients. Breast J. 2008;14:164-8.
39. Krompecher E. Zurhistogenese und morphologie der cystenmamma (mala-
diekystique reclus, cystadenomaschimmelbuscin, mastitis chronica cystic ko-
nig) des intrakanalikenkystadenomas under kystadenokarzinome der brust-
druse (hidro-kystoma, kystadenoma, hidrokystadenocarzinomamammae). Beitr 
Pathol Anat. 1916;62:403-9.
40. Vega Gutiérrez J, Rodríguez MA. Carcinoma erysipeloides associated with 
breast carcinoma. Int J Dermatol. 2007;46:613-4.
41. Lee BJ, Tannenbaum N. Inflammatory carcinoma of the breast: a report of 
twenty-eight cases from the breast clinic of Memorial Hospital. Surg Gynecol 
Obstet.1924;39:580-95.
42. Rasch C. Carcinoma erysipelatodes. Br J Dermatol Syphilol. 1931;43:351-4.
43. Kim M, Lee DW, Im J, Suh KJ, Keam B, Moon HG, et al. Adenoid cystic carcino-
ma of the breast: a case series of six patients and literature review. Cancer Res 
Treat. 2014;46:93-7.
437
44. Billroth T. Beobachtungen über geschulste der spercheldrusen. Arch path 
Anat. 1859;17:357.
45. Geschickter CF, Copeland MM. Diseases of the Breast: Diagnosis, Pathology, 
and Treatment. Philadelphia: Lippincott; 1945.
46. Sikora MJ, Jankowitz RC, Dabbs DJ, Oesterreich S. Invasive lobular carcinoma 
of the breast: patient response to systemic endocrine therapy and hormone re-
sponse in model systems. Steroids. 2013;78:568-75.
47. Foote FJ, Stewart FW.A histologic classification of carcinoma of the breast. 
Surgery. 1946;19:74-99.
48. Jeong SJ, Lim HS, Lee JS, Park MH, Yoon JH, Park JG, et al. Medullary carcinoma 
of the breast: MRI findings. AJR Am J Roentgenol. 2012;198:W482-7.
49. Moore OS, Foote FW. The relatively favorable prognosis of medullary carcino-
ma of the breast. Cancer. 1949;2:635-42.
50. Guan B, Wang H, Cao S, Rao Q, Wang Y, Zhu Y, et al. Lipid-rich carcinoma of the 
breast clinicopathologic analysis of 17 cases. Ann Diagn Pathol. 2011;15:225-32.
51. Tsubura A, Hatano T, Murata A, Shoji T, Shikata N, Morii S. Breast carcinoma 
in patients receiving neuroleptic therapy. Morphologic and clinicopathologic 
features of thirteen cases. Acta Pathol Jpn. 1992;42:494-9.
52. Aboumrad MH, Horn RC, Fine G. Lipid-secreting mammary carcinoma. 
Cancer. 1963;16:521-5.
53. Gabal S, Talaat S. Secretory carcinoma of male breast: case report and review of 
the literature. Int J Breast Cancer. 2011;2011:704657.
54. McDivitt RW, Stewart FW. Breast carcinoma in children. JAMA. 
1966;195:388-90.
55. Yoon JY, Chitale D. Adenomyoepithelioma of the breast: a brief diagnostic re-
view. Arch Pathol Lab Med. 2013;137:725-9. 
56. Hamperl H. The myothelia (myoepithelial cells). Normal state; regressive chang-
es; hyperplasia; tumors. Curr Top Pathol. 1970;53:161-220.
57. Wheeler DT, Tai LH, Bratthauer GL. Tubulolobular carcinoma of the breast: an 
analysis of 27 cases of a tumor with a hybrid morphology and immunoprofile. 
Am J Surg Pathol. 2004;28:1587-93.
58. Fisher ER, Gregorio RM, Redmond C, Fisher B. Tubulolobular invasive breast 
cancer: a variant of lobular invasive cancer. Hum Pathol. 1977;8:679-83.
59. Resetkova E, Sahin A, Ayala AG, Sneige N. Breast carcinoma with choriocarci-
nomatous features. Ann Diagn Pathol. 2004;8:74-9. 
60. Saigo PE, Rosen PP. Mammary carcinoma with “choriocarcinomatous” features. 
Am J SurgPathol. 1981;5:773-8.
61. Salemis NS. Intraductal glycogen-rich clear cell carcinoma of the breast: a rare 
presentation and review of the literature. Breast Care (Basel). 2012;7:319-21.
438
62. Hull MT, Priest JB, Broadie TA, Ransburg RC, McCarthy LJ. Glycogen-rich 
clear cell carcinoma of the breast: a light and electron microscopic study. Cancer. 
1981;48:2003-9.
63. Soo K, Tan PH. Low-grade adenosquamous carcinoma of the breast. J Clin 
Pathol. 2013;66:506-11.
64. Rosen PP, Ernsberger D. Low-grade adenosquamous carcinoma. A variant of 
metaplastic mammary carcinoma. Am J Surg Pathol. 1987;11:351-8.
65. Gokce H, Durak MG, Akin MM, Canda T, Balci P, Ellidokuz H, et al. Invasive 
micropapillary carcinoma of the breast: a clinicopathologic study of 103 cas-
es of an unusual and highly aggressive variant of breast carcinoma. Breast J. 
2013;19:374-81.
66. Siriaunkgul S, Tavassoli FA. Invasive micropapillary carcinoma of the breast. 
Mod Pathol. 1993;6:660-2.
67. Damiani S, Pasquinelli G, Lamovec J, Peterse JL, Eusebi V. Acinic cell carcino-
ma of the breast: an immunohistochemical and ultrastructural study. Virchows 
Arch. 2000;437:74-81.
68. Roncaroli F, Lamovec J, Zidar A, Eusebi V. Acinic cell-like carcinoma of the 
breast. Virchows Arch. 1996;429:69-74.
69. Singal R, Dalal AK, Dalal U, Attri AK. Primary tuberculosis of the breast pre-
sented as multiple discharge sinuses. Indian J Surg.2013;75:66-7.
70. Cooper A. Illustrations of the diseases of the breast. Part I. London: Longman, 
Rees, Orme, Brown and Green; 1829.p.73.
71. Hutchison RL, Rayan GM. Astley Cooper: his life and surgical contributions. J 
Hand Surg Am. 2011;36:316-20.
72. Al-Masri M, Darwazeh G, Sawalhi S, Mughrabi A, Sughayer M, Al-Shatti M. 
Phyllodes tumor of the breast: role of CD10 in predicting metastasis. Ann Surg 
Oncol. 2012;19:1181-4.
73. Muller J. Über den feineren bau und die formen der krankhaften geschwülste. 
Berlin: G. Reimer;1838.
74. Chung-Park M, Zheng Liu C, Giampoli EJ, Emery JD, Shalodi A. Mucinous 
adenocarcinoma of ectopic breast tissue of the vulva. Arch Pathol Lab Med. 
2002;126:1216-8.
75. Francone E, Nathan MJ, Murelli F, Bruno MS, Traverso E, Friedman D. Ectopic 
breast cancer: case report and review of the literature. Aesthetic Plast Surg. 
2013;37:746-9.
76. Hartung. Inaugural dissertation. Erlangen; 1872.
77. Greene HJ.Adenocarcinoma of supernumerary breasts of the labia majora in a 
case of epidermoid carcinoma of the vulva. Am J Obstet Gynecol. 1936;2:660-3.
439
78. Varadarajan R, Edge SB, Yu J, Watroba N, Janarthanan BR. Prognosis of occult 
breast carcinoma presenting as isolated axillary nodal metastasis. Oncology. 
2006;71:456-9.
79. Halsted WS.The results of radical operations for the cure of carcinoma of the 
breast. Ann Surg. 1907;46:1-19.
80. Osborne MP. William Stewart Halsted: his life and contributions to surgery. 
Lancet Oncol. 2007;8:256-65.
81. Strandberg J. Contribution á la question de la clinique et de la pathologénie de 
la sarcoide de Boeck. Acta Derm Venerol. 1921;2:252-61.
82. Scott RB. The sarcoidosis of Boeck. Br Med J. 1938;2:777.
83. Sonmez FC, Gucin Z, Yildiz P, Tosuner Z. Hamartoma of the breast in two pa-
tients: A case report. Oncol Lett. 2013;6:442-4.
84. Arrigoni MG, Dockerty MB, Judd ES.The identification and treatment of mam-
mary hamartoma. Surg Gynecol Obstet. 1971;133:577-82.
85. Mohammed S, Statz A, Lacross JS, Lassinger BK, Contreras A, Gutierrez C, et 
al. Granulomatous mastitis: a 10 year experience from a large inner city county 
hospital. J Surg Res. 2013;184:299-303.
86. Kessler E, Woolloch Y. Granulomatous mastitis: a lesion clinically simulating 
carcinoma. Am J Clin Pathol.1972;58:642-6.
87. Ely KA, Tse G, Simpson JF, Clarfeld R, Page DL. Diabetic mastopathy. A clini-
copathologic review. Am J Clin Pathol. 2000;113:541-5.
88. Soler NG, Khardori R. Fibrous disease of the breast, thyroiditis, and cheiroar-
thropathy in type I diabetes mellitus. Lancet. 1984;1:193-5
Sažetak
Maligne bolesti dojki su jedan od najčešćih i glavnih uzroka pobola i smrtnosti među ženama 
diljem svijeta. Prema dostupnim podacima, tumorske lezije dojke su jedan od glavnih uzroka 
koji dovode do teških troškova i za zdravstveni sustav i za društvo. Na temelju tih danosti i 
činjenici da su različiti aspekti tih malignih bolesti i dalje nepoznati do danas, te se tek treba-
ju odrediti, ta pitanja čine ogromno područje istraživanja u medicini. Baš kao i u sadašnjem 
trenutku, karcinom dojke je bio i u prošlosti u fokusu znanstvenika iz svih krajeva svijeta. 
Prema tome ove zloćudne bolesti su skupina bolesti s dugogodišnjom povijesnom pozadinom. 
Možemo, kao rezultat, tvrditi da suvremena znanja o tim pitanjima je procvjetalo s izvanred-
nim otkrićima i razvojem dijagnostičkih i terapijskih metoda kroz stoljeća, a posebno u onim 
one nakon srednjeg vijeka. Prepoznajući prethodne napore koji su uloženi u tom pogledu 
pokazat će nam put za budućnost. Iz tog razloga, u ovom radu ćemo dati pregled ključnih 
prekretnica i važnih otkrića na području tmora dojke i nekih drugih bolesti koje uključuju 
taj organ.
Ključne riječi: karcinom dojke; dijagnoza; povijest medicine.
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